Grant Pickering, CHIEF EXECUTIVE OFFICER at Vaxcyte, Inc. (PCVX), sold 2,616 shares at $63.84 ($161K) on 2024-05-01, disclosed to the SEC on 2024-05-03.
Scheduled sale ($161k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.25 | 728 | $45K | 27.6% |
| 2 | $61.28 | 680 | $42K | 25.8% |
| 3 | $62.01 | 508 | $32K | 19.5% |
| 4 | $62.07 | 582 | $36K | 22.4% |
| 5 | $63.84 | 46 | $3K | 1.8% |
| 6 | $63.87 | 72 |
| $5K |
| 2.8% |
| Total | $61.71 avg | 2,616 | $161K | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $1.2M | — | Filing → |
| PCVX | SELL | 2024-12-10 | $401K | — | Filing → |
| PCVX | SELL | 2024-12-03 | $2.8M | — | Filing → |